TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9627237

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg intravenously)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Droperidol (25 microg/kg intravenously)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 120
Study: 7946179

Group type: EXPERIMENTAL
Intervention: Isradipine at 2.5 mg/day
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nitrendipine at 10 mg/day
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nitrendipine at 10 mg/day + Aspirin at 100 mg/day
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Isradipine at 2.5 mg/day + Aspirin at 100 mg/day
Number of subjects: 39
Study: 3182156

Group type: COMPARATOR
Intervention: Moderate-protein (0.8 g.kg‐1.d‐1), high-carbohydrate hypoenergy diet (MP/HC)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-protein (1.6 g.kg‐1.d‐1), moderate-carbohydrate hypoenergy diet (HP/MC)
Number of subjects: 19
Study: 31311598

Group type: EXPERIMENTAL
Intervention: PCV7 (3 doses)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Unvaccinated
Number of subjects: 132
Study: 28162851

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 6503

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 6503

Group type: EXPERIMENTAL
Intervention: RCT subgroup analysis of TAVI
Number of subjects: 6503

Group type: EXPERIMENTAL
Intervention: PSM subgroup analysis of TAVI
Number of subjects: 6503
Study: 26314530

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment
Number of subjects: 0
Study: 24013347

Group type: EXPERIMENTAL
Intervention: Surgical treatment with accelerated rehabilitation protocol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 100
Study: 20813577

Group type: EXPERIMENTAL
Intervention: Thoracic manipulation (TM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no TM)
Number of subjects: 120
Study: 19061152

Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg t.i.d for 20 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 15964035

Group type: EXPERIMENTAL
Intervention: Implicit learning of integrated spatial/stimulus-response sequence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implicit learning of spatial sequence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implicit learning of stimulus-response sequence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impaired integrated sequence acquisition
Number of subjects: 0
Study: 12866134

Group type: EXPERIMENTAL
Intervention: Atrial pacing
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Beta-blockers (control)
Number of subjects: 36
Study: 10370677

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus high-dose, intermittent IL-2 (2.1 x 10(6) U twice weekly)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus low-dose, continuous IL-2 (7 x 10(5) U daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 46
Study: 8912507

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of Fluoxetine and Amitriptyline
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI) scale
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Physician global VAS
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VAS for fatigue
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VAS for feeling refreshed upon awakening
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tender point score
Number of subjects: 19
Study: 1676832

Group type: EXPERIMENTAL
Intervention: Idazoxan (40 mg tid)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6859669

Group type: EXPERIMENTAL
Intervention: Tidal volume (V(T)) of 14 ml/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tidal volume (V(T)) of 11 ml/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tidal volume (V(T)) of 7 ml/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High tidal volume (>12 ml/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High tidal volume
Number of subjects: 16
Study: 31251167

Group type: EXPERIMENTAL
Intervention: CRANAPL tool (mean total score 6.4, SD 2.2)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Notes from academic hospitals (mean score 7.4, SD 2.0 and 6.6, SD 2.1)
Number of subjects: 120
Study: 30795490

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 52
Study: 28264692

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) provided by a multidisciplinary team
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) provided by a multidisciplinary team and Short Message Service (SMS)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 210
Study: 25919473

Group type: EXPERIMENTAL
Intervention: Intra-articular corticosteroid injection
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combined intra-articular and rotator interval injection
Number of subjects: 122

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Intra-articular corticosteroid injection and Combined intra-articular/interval injection
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (night pain, Shoulder Pain and Disability Index)
Number of subjects: 122
Study: 23332183

Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 35

Group type: COMPARATOR
Intervention: aprotinin and tranexamic acid
Number of subjects: 35

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 35
Study: 21279511

Group type: EXPERIMENTAL
Intervention: Glutamine (3 g/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study: 19840637

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:50,000 epinephrine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3% mepivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study: 17119142

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 954

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 954
Study: 14670578

Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI) analysis in NF-I participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Functional MRI (fMRI) analysis in healthy control participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral performance on the fMRI task in NF-I participants
Number of subjects: 0
Study: 11503993

Group type: EXPERIMENTAL
Intervention: Single-cone technique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: System B
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thermafil
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vertical condensation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lateral condensation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 50
Study: 9762482

Group type: EXPERIMENTAL
Intervention: Needle biopsy of the right vastus lateralis muscle
Number of subjects: 19

Group type: COMPARATOR
Intervention: Isokinetic testing for knee extension and flexion
Number of subjects: 19
Study: 7530601

Group type: EXPERIMENTAL
Intervention: Pooled serum specimens (10 specimens pooled)
Number of subjects: 0
Study: 3246316

Group type: EXPERIMENTAL
Intervention: Supine posture during dynamic exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Upright posture during dynamic exercise
Number of subjects: 20
Study: 29590407

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim
Number of subjects: 346

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study: 25070967

Group type: EXPERIMENTAL
Intervention: Mailed tailored interactive DVD
Number of subjects: 1681

Group type: EXPERIMENTAL
Intervention: Computer-tailored telephone counseling
Number of subjects: 1681

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1681
Study: 25581711

Group type: EXPERIMENTAL
Intervention: Rectus sheath block using bupivacaine plus adrenaline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 0
Study: 23062837

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX), mean daily dosage 71.6±14.9mg, treatment duration 12 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 43
Study: 21741092

Group type: EXPERIMENTAL
Intervention: Grass AIT (Phleum pratense grass pollen allergen extract), once-daily for 8 to 10 weeks
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 18077218

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 106
Study: 17070287

Group type: EXPERIMENTAL
Intervention: Training on the simulator (2 sessions of 30 minutes each)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no further training)
Number of subjects: 63
Study: 12569211

Group type: EXPERIMENTAL
Intervention: low‐flow‐high‐pressure IMT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: high‐flow‐low‐pressure IMT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: intermediate flow‐pressure IMT
Number of subjects: 24

Group type: COMPARATOR
Intervention: no IMT
Number of subjects: 24

Group type: COMPARATOR
Intervention: detraining group (no IMT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: maintenance group (IMT 2 d.wk(‐1))
Number of subjects: 24
Study: 11124669

Group type: COMPARATOR
Intervention: Anterior transposition of the inferior oblique muscle (ATIO) without resection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anterior transposition of the inferior oblique muscle (ATIO) with a 7-mm resection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (standard ATIO and ATIO with resection)
Number of subjects: 30
Study: 8777215

Group type: EXPERIMENTAL
Intervention: 1-minute exercise protocol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3-minute exercise protocol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Both protocols
Number of subjects: 9
Study: 1328364

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg) + Benazepril (10 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Benazepril (10 mg)
Number of subjects: 9
Study: 6108817

Group type: EXPERIMENTAL
Intervention: SKF 92 657 at 1.0 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SKF 92 657 at 2.0 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SKF 92 657 at 4.0 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SKF 92 657 at 8.0 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SKF 92 657 continued for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SKF 92 657 during dynamic exercise
Number of subjects: 0
Study: 31159849

Group type: EXPERIMENTAL
Intervention: ASICA intervention (tablet-based digital intervention to prompt and support TSSE)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 240
Study: 27853163

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 200 mg QD, uptitrated to 400 mg QD if BP uncontrolled after 4 weeks, followed by amlodipine 5-10 mg and hydrochlorothiazide 6.25-25 mg if needed
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 200 mg QD
Number of subjects: 341
Study: 25483230

Group type: EXPERIMENTAL
Intervention: Lutein and Zeaxanthin supplements (n=54)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (n=15)
Number of subjects: 69
Study: 23729939

Group type: EXPERIMENTAL
Intervention: Experienced ENT surgeons
Number of subjects: 97

Group type: COMPARATOR
Intervention: Nonexperienced ENT surgeons
Number of subjects: 97
Study: 20390272

Group type: EXPERIMENTAL
Intervention: Standard pushable coils
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Interlock detachable coils (IDC)
Number of subjects: 50
Study: 19845256

Group type: EXPERIMENTAL
Intervention: Topical 10% phenylephrine cream
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo cream (Control)
Number of subjects: 12
Study: 17893000

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pumping (IABP)
Number of subjects: 16
Study: 17409898

Group type: EXPERIMENTAL
Intervention: Docetaxel and gemcitabine (DG)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Docetaxel and cisplatin (DC)
Number of subjects: 133
Study: 14573714

Group type: EXPERIMENTAL
Intervention: Home exercise programme (8 weeks, five shoulder stretching and strengthening exercises)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Home exercise programme
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 10084633

Group type: EXPERIMENTAL
Intervention: Lamotrigine 200 mg/day
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Lamotrigine 50 mg/day
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 8640150

Group type: EXPERIMENTAL
Intervention: Broncho-Vaxom
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (10 healthy persons)
Number of subjects: 16
Study: 2277573

Group type: EXPERIMENTAL
Intervention: Touhy needle pointed upward (parallel to the ligament flavum)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Touhy needle pointed caudally
Number of subjects: 40
Study: 6786071

Group type: EXPERIMENTAL
Intervention: Protein-calorie replacement therapy (immediate sensitization to dinitrochlorobenzene)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Protein-calorie replacement therapy (sensitization after 1 week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Protein-calorie replacement therapy (sensitization after 2 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Protein-calorie replacement therapy (sensitization after 3 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Attempted sensitization before refeeding in children with total serum proteins < 4.5 g/dl
Number of subjects: 50
Study: 31390688

Group type: EXPERIMENTAL
Intervention: SFE with NMES
Number of subjects: 36

Group type: COMPARATOR
Intervention: SFE alone
Number of subjects: 36
Study: 28549665

Group type: EXPERIMENTAL
Intervention: High nitrate‐containing beetroot juice (BRJ) consumed daily (8 mmol nitrate for HTN) or three times a week (6.1 mmol nitrate for HFpEF)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (beet juice beverage with the nitrate removed)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: High nitrate‐containing beetroot juice (BRJ)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both BRJ and placebo
Number of subjects: 46
Study: 25163639

Group type: EXPERIMENTAL
Intervention: Probiotic preparation containing Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Bifidobacterium lactis, fructooligosaccharide, galactooligosaccharide, colostrums and lactoferrin (NBL probiotic ATP®)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 210
Study: 23474363

Group type: EXPERIMENTAL
Intervention: Capecitabine (830 mg/m² twice daily, Monday to Friday) with radiation (50.4 Gy in 28 fractions)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Gemcitabine (300 mg/m² once per week) with radiation (50.4 Gy in 28 fractions)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Gemcitabine
Number of subjects: 74
Study: 21320365

Group type: EXPERIMENTAL
Intervention: 20 g RBO spread (RBOS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 20 g phytosterol-enriched spread (PS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 20 g standard spread (SS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 20 g RBOS plus 30 ml RBO
Number of subjects: 80

Group type: COMPARATOR
Intervention: 20 g SS plus 30 ml sunflower oil
Number of subjects: 80
Study: 18487628

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1043
Study: 16686387

Group type: EXPERIMENTAL
Intervention: Buffered hypertonic saline (HS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Normal saline (NS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No spray (control)
Number of subjects: 60
Study: 14748452

Group type: EXPERIMENTAL
Intervention: Communication skills training (2 hours/week for 6 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (47 young adolescents and a parent who did not participate in the training)
Number of subjects: 37
Study: 10788675

Group type: EXPERIMENTAL
Intervention: Physical exercise (1-h pedaling on a bicycle ergometer between 13.00 and 14.00 h)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Bright light treatment (2-h exposure to 2500 lux between 14.00 and 16.00 h)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Bright light treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Physical exercise and bright light treatment
Number of subjects: 63
Study: 8840941

Group type: EXPERIMENTAL
Intervention: Intravenous push of iron dextran 100 mg over 2 minutes (undiluted)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous infusion of iron dextran 100 mg over 30 minutes
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cost-minimization analysis of intravenous push administration
Number of subjects: 10
Study: 1531488

Group type: EXPERIMENTAL
Intervention: Chiropractic manipulation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Stroking massage
Number of subjects: 63

Group type: COMPARATOR
Intervention: Corset
Number of subjects: 63

Group type: COMPARATOR
Intervention: Transcutaneous muscular stimulation (TMS)
Number of subjects: 63
Study: 6401911

Group type: EXPERIMENTAL
Intervention: Cysteine‐HCl supplemented total parenteral nutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Automated amino acid analysis measuring 1/2 cystine
Number of subjects: 0
Study: 31014060

Group type: EXPERIMENTAL
Intervention: CAD/CAM splints and patient specific osteosynthesis for maxillary positioning
Number of subjects: 32

Group type: COMPARATOR
Intervention: Occlusal wafers fabricated on a semi‐adjustable articulator
Number of subjects: 32
Study: 30382737

Group type: EXPERIMENTAL
Intervention: iDOVE intervention (cognitive-behavioral therapy and motivational interviewing-based intervention with a brief in-ED session and 8 weeks of automated text-message daily mood queries)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control (brief in-ED presentation and twice-weekly text messages on healthy behaviors)
Number of subjects: 116
Study: 27022679

Group type: EXPERIMENTAL
Intervention: Oral 50,000 IU/wk Vitamin D3 (cholecalciferol) for 52 weeks
Number of subjects: 746

Group type: COMPARATOR
Intervention: Placebo (control group) for 52 weeks
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Oral 50,000 IU/wk Vitamin D3 (cholecalciferol) for 52 weeks (stratified by depression types)
Number of subjects: 746
Study: 24964217

Group type: EXPERIMENTAL
Intervention: Bupivacaine infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (physiologic saline)
Number of subjects: 40
Study: 22364367

Group type: EXPERIMENTAL
Intervention: Involvement of the fascia during placement of the anastomotic sutures
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Urethral irrigation
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Both involvement of the fascia and urethral irrigation
Number of subjects: 260

Group type: COMPARATOR
Intervention: Neither involvement of the fascia nor urethral irrigation
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Overall trial methodology
Number of subjects: 260
Study: 20630682

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (nadroparin 180 anti-activated factor X units once daily for 10 days) plus compression therapy for three months
Number of subjects: 107

Group type: COMPARATOR
Intervention: Compression therapy alone
Number of subjects: 107
Study: 17959578

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (400 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15222593

Group type: EXPERIMENTAL
Intervention: Brief intervention (counseling session and health information packet)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group (health information packet only)
Number of subjects: 194
Study: 11237159

Group type: EXPERIMENTAL
Intervention: Encouraged to self‐propel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Discouraged from self‐propulsion
Number of subjects: 40
Study: 9203881

Group type: EXPERIMENTAL
Intervention: Neostigmine (100 micrograms in 1 ml of saline)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Morphine (100 micrograms in 1 ml of saline)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal saline (1 ml)
Number of subjects: 36
Study: 7970115

Group type: EXPERIMENTAL
Intervention: Individualized dialysis prescription using urea kinetic modelling (UKM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 56
Study: 3308737

Group type: EXPERIMENTAL
Intervention: Calcium treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ascorbic acid (1 g twice daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both treatments (Calcium and Ascorbic acid)
Number of subjects: 60
Study: 29028973

Group type: EXPERIMENTAL
Intervention: Newborn MVA85A vaccination (1 × 10^8 PFU)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Candin® control
Number of subjects: 248